BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11711876)

  • 1. Brain prolyl oligopeptidase activity is associated with neuronal damage rather than beta-amyloid accumulation.
    Laitinen KS; van Groen T; Tanila H; Venäläinen J; Männistö PT; Alafuzoff I
    Neuroreport; 2001 Oct; 12(15):3309-12. PubMed ID: 11711876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrillary beta-amyloid deposits are closely associated with atrophic nitric oxide synthase (NOS)-expressing neurons but do not upregulate the inducible NOS in transgenic Tg2576 mouse brain with Alzheimer pathology.
    Hartlage-Rübsamen M; Apelt J; Schliebs R
    Neurosci Lett; 2001 Apr; 302(2-3):73-6. PubMed ID: 11290390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology.
    Su JH; Zhao M; Anderson AJ; Srinivasan A; Cotman CW
    Brain Res; 2001 Apr; 898(2):350-7. PubMed ID: 11306022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrillar amyloid-beta affects neurofibrillary changes but only in neurons already involved in neurofibrillary degeneration.
    Wegiel J; Bobinski M; Tarnawski M; Dziewiatkowski J; Popovitch E; Miller DC; Wisniewski T; Golomb J; de Leon MJ; Reisberg B
    Acta Neuropathol; 2001 Jun; 101(6):585-90. PubMed ID: 11515787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tph2 Genetic Ablation Contributes to Senile Plaque Load and Astrogliosis in APP/PS1 Mice.
    Xu CJ; Wang JL; Jing-Pan ; Min-Liao
    Curr Alzheimer Res; 2019; 16(3):219-232. PubMed ID: 30827242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of caspase cleaved amyloid precursor protein represents an early neurodegenerative event in aging and in Alzheimer's disease.
    Zhao M; Su J; Head E; Cotman CW
    Neurobiol Dis; 2003 Dec; 14(3):391-403. PubMed ID: 14678756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
    He SR; Liu DG; Wang S; Xia YJ
    Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's-type neuropathology in the precuneus is not increased relative to other areas of neocortex across a range of cognitive impairment.
    Nelson PT; Abner EL; Scheff SW; Schmitt FA; Kryscio RJ; Jicha GA; Smith CD; Patel E; Markesbery WR
    Neurosci Lett; 2009 Feb; 450(3):336-9. PubMed ID: 19010392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.
    Kirouac L; Rajic AJ; Cribbs DH; Padmanabhan J
    eNeuro; 2017; 4(2):. PubMed ID: 28374012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drastic neuronal loss in vivo by beta-amyloid racemized at Ser(26) residue: conversion of non-toxic [D-Ser(26)]beta-amyloid 1-40 to toxic and proteinase-resistant fragments.
    Kaneko I; Morimoto K; Kubo T
    Neuroscience; 2001; 104(4):1003-11. PubMed ID: 11457586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease.
    Mizukami K; Akatsu H; Abrahamson EE; Mi Z; Ikonomovic MD
    Neuropathology; 2016 Apr; 36(2):135-45. PubMed ID: 26293308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine oxidase inhibitors: promising therapeutic agents for Alzheimer's disease (Review).
    Cai Z
    Mol Med Rep; 2014 May; 9(5):1533-41. PubMed ID: 24626484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of hippocalcin in mediating Aβ toxicity.
    Lim YA; Giese M; Shepherd C; Halliday G; Kobayashi M; Takamatsu K; Staufenbiel M; Eckert A; Götz J
    Biochim Biophys Acta; 2012 Aug; 1822(8):1247-57. PubMed ID: 22542901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducible nitric oxide synthase immunoreactivity in the Alzheimer disease hippocampus: association with Hirano bodies, neurofibrillary tangles, and senile plaques.
    Lee SC; Zhao ML; Hirano A; Dickson DW
    J Neuropathol Exp Neurol; 1999 Nov; 58(11):1163-9. PubMed ID: 10560659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.
    Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I
    J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease.
    Selznick LA; Holtzman DM; Han BH; Gökden M; Srinivasan AN; Johnson EM; Roth KA
    J Neuropathol Exp Neurol; 1999 Sep; 58(9):1020-6. PubMed ID: 10499444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parvalbumin-Positive Neuron Loss and Amyloid-β Deposits in the Frontal Cortex of Alzheimer's Disease-Related Mice.
    Ali F; Baringer SL; Neal A; Choi EY; Kwan AC
    J Alzheimers Dis; 2019; 72(4):1323-1339. PubMed ID: 31743995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cdk5: one of the links between senile plaques and neurofibrillary tangles?
    Lee MS; Tsai LH
    J Alzheimers Dis; 2003 Apr; 5(2):127-37. PubMed ID: 12719630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.